Alessandro Casini Selected Research

Congenital Dysfibrinogenemia

11/2021	How I treat dysfibrinogenemia.
1/2018	Heterozygous FGA p.Asp473Ter (fibrinogen Nieuwegein) presenting as antepartum cerebral thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Casini Research Topics

Disease

24	Hemorrhage 03/2024 - 09/2013
16	Afibrinogenemia (Fibrinogen Deficiency) 03/2024 - 09/2013
15	Thrombosis (Thrombus) 01/2024 - 06/2016
6	Venous Thromboembolism 11/2023 - 09/2016
5	Neoplasms (Cancer) 02/2023 - 09/2008
5	Overweight 08/2020 - 09/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 05/2016 - 09/2008
4	Venous Thrombosis (Deep-Vein Thrombosis) 12/2022 - 06/2016
4	Chronic Disease (Chronic Diseases) 11/2017 - 11/2007
4	Non-alcoholic Fatty Liver Disease 06/2014 - 09/2006
3	Hemophilia A (Haemophilia) 01/2024 - 12/2020
3	COVID-19 05/2022 - 01/2020
3	Pulmonary Embolism 05/2022 - 04/2013
3	Fibrosis (Cirrhosis) 01/2020 - 06/2002
2	Rare Diseases (Rare Disease) 09/2022 - 06/2016
2	Congenital Dysfibrinogenemia 11/2021 - 01/2018
2	Disease Progression 01/2021 - 06/2016
2	Infections 01/2021 - 09/2003
2	Thromboembolism 12/2019 - 09/2013
2	Obesity 02/2018 - 09/2006
2	Fatty Liver 01/2018 - 09/2006
2	Body Weight (Weight, Body) 01/2018 - 07/2013
2	Thyroid Nodule (Nodule, Thyroid) 03/2017 - 01/2017
2	Hematologic Neoplasms (Hematological Malignancy) 01/2015 - 09/2014
2	Weight Loss (Weight Reduction) 06/2014 - 09/2012
2	Stroke (Strokes) 04/2013 - 06/2012
2	Insulin Resistance 10/2011 - 09/2006
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2010 - 03/2009
2	Alzheimer Disease (Alzheimer's Disease) 01/2010 - 09/2008
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2002 - 06/2002
1	Telangiectasis (Telangiectasia) 03/2024
1	von Willebrand Diseases (von Willebrand's Disease) 03/2024
1	Factor XIII Deficiency 02/2024
1	Wounds and Injuries (Trauma) 01/2024
1	Menorrhagia 06/2023
1	Atrial Fibrillation 02/2023
1	Breast Neoplasms (Breast Cancer) 10/2022
1	Critical Illness (Critically Ill) 05/2022
1	Congenital Hypodysfibrinogenemia 01/2021
1	Metrorrhagia (Spotting) 12/2020
1	Uterine Hemorrhage (Uterine Bleeding) 12/2020
1	Hepatitis 10/2020

Drug/Important Bio-Agent (IBA)

24	Fibrinogen (Factor I)FDA Link 03/2024 - 09/2013
6	FibrinIBA 12/2022 - 01/2018
5	AntigensIBA 01/2024 - 09/2013
5	AnticoagulantsIBA 01/2023 - 12/2018
4	Thrombin FDA Link 11/2023 - 11/2019
3	RivaroxabanIBA 02/2024 - 01/2023
3	Factor XIII (Coagulation Factor XIII)IBA 02/2024 - 01/2019
3	Factor VIII (Coagulation Factor VIII)IBA 10/2023 - 12/2020
3	EnzymesIBA 10/2023 - 12/2010
3	Antiphospholipid AntibodiesIBA 10/2023 - 12/2018
3	LipidsIBA 04/2017 - 10/2011
2	Blood Coagulation Factors (Coagulation Factor)IBA 03/2024 - 03/2024
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 03/2024 - 01/2024
2	Hemostatics (Antihemorrhagics)IBA 03/2024 - 01/2021
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2024 - 12/2018
2	Glycoproteins (Glycoprotein)IBA 10/2023 - 10/2023
2	emicizumabIBA 10/2023 - 12/2020
2	AntibodiesIBA 10/2023 - 10/2023
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 10/2023 - 10/2023
2	Immunoglobulin G (IgG)IBA 10/2023 - 10/2023
2	Immunoglobulin M (IgM)IBA 10/2023 - 10/2023
2	ImmunosorbentsIBA 10/2023 - 10/2023
2	fibrin fragment D (D-dimer)IBA 05/2022 - 01/2022
2	Heparin (Liquaemin)FDA LinkGeneric 01/2020 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 05/2005
2	Glucose (Dextrose)FDA LinkGeneric 04/2017 - 05/2016
2	Triglycerides (Triacylglycerol)IBA 05/2016 - 12/2010
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2011 - 12/2009
2	AdiponectinIBA 12/2010 - 09/2006
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2010 - 09/2006
2	LigandsIBA 09/2006 - 06/2002
2	CollagenIBA 05/2005 - 06/2002
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 03/2024
1	Angiogenesis InhibitorsIBA 03/2024
1	ThrombomodulinIBA 03/2024
1	Thromboplastin (Tissue Factor)IBA 03/2024
1	concizumabIBA 01/2024
1	Contraceptive Agents (Contraceptives)IBA 11/2023
1	von Willebrand FactorIBA 06/2023
1	prothrombin complex concentrates (PPSB)IBA 01/2023
1	apixabanIBA 01/2023
1	edoxabanIBA 01/2023
1	PRT064445IBA 01/2023
1	Factor Xa InhibitorsIBA 01/2023
1	Tamoxifen FDA LinkGeneric 10/2022
1	Aromatase InhibitorsIBA 10/2022
1	Enoxaparin (Lovenox)FDA LinkGeneric 05/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2022
1	Dacarbazine (DIC)FDA LinkGeneric 05/2022
1	Nonsense Codon (Nonsense Mutation)IBA 12/2020
1	Combined Oral ContraceptivesIBA 12/2020
1	16S Ribosomal RNAIBA 08/2020

Therapy/Procedure

9	Mediterranean Diet 02/2018 - 09/2008
5	Therapeutics 02/2024 - 11/2002
4	Vegetarian Diet (Vegetarianism) 01/2018 - 05/2016
2	Ligation 01/2020 - 06/2002
1	Anticoagulation Reversal 01/2023
1	Contraception (Birth Control) 12/2020